Eubacterium rectale: Measuring a Major Butyrate Producer in Your Gut
The Eubacterium rectale test measures the abundance of Eubacterium rectale in a stool sample. Labs typically analyze microbial DNA using methods like 16S rRNA gene sequencing, shotgun metagenomics, or targeted qPCR to estimate how much of this species is present relative to the rest of your gut community. Results are usually reported as a percentage, percentile, or reads per million, reflecting your current microbiome snapshot rather than a fixed trait. Because taxonomy is evolving, some reports group this organism with closely related butyrate producers or label it within the E. rectale–Roseburia complex; a few databases use updated genus names that can differ by lab.
Why focus on this microbe? Eubacterium rectale is a prominent producer of butyrate, a short‑chain fatty acid that fuels colon cells, strengthens the intestinal barrier, and shapes immune balance. Butyrate supports tight junctions, promotes regulatory T‑cell activity, and helps keep inflammatory signaling in check. In observational research, lower levels of E. rectale and other butyrate producers are often seen with inflammatory bowel conditions and metabolic risk profiles, while fiber‑rich eating patterns tend to correlate with higher levels—though more research is needed to define precise targets for individuals.
Why This One Species Earns Its Own Test
This test connects a single, well‑studied function of the gut ecosystem—butyrate production—to everyday health questions. If your Eubacterium rectale is low, it can suggest reduced capacity to generate butyrate from fermentable fibers found in foods like beans, oats, and cooked‑and‑cooled grains and potatoes. That may map to symptoms such as stool inconsistency, gas, or gut sensitivity, or to contexts like recent antibiotic use, a very low‑fiber diet, or prolonged stress. If it’s robust, you may have a helpful buffer for barrier integrity and inflammatory tone. Either way, the result doesn’t diagnose a condition; it points to how your gut’s fuel supply for the colon lining is trending right now.
Zooming out, Eubacterium rectale acts like a sentinel for a microbiome that can turn fiber into health‑protective metabolites. Butyrate interacts with glucose regulation, gut–brain signaling, and systemic inflammation, which is why this single marker can be informative beyond digestion. Re‑checking after meaningful changes—like adjusting fiber sources, recovering from antibiotics, or shifting training loads—helps you see if the microbiome is moving in a resilient direction. The aim isn’t a “perfect” number. It’s learning how your gut responds over time so you and your clinician can make grounded, data‑informed decisions.
Putting a Eubacterium rectale Number on a Mental Map
Most reports show your Eubacterium rectale as a relative abundance compared with a reference population. In general, balanced gut ecosystems feature a healthy representation of butyrate producers (including Eubacterium rectale, Faecalibacterium, and certain Roseburia species) alongside overall microbial diversity. A value near or above population medians often aligns with stronger butyrate generation, while a value well below peers can flag limited fermentation of fiber into short‑chain fatty acids. “Normal” ranges vary by lab, geography, and diet patterns, so context matters when interpreting cutoffs.
When this marker looks “optimal” for you, it suggests efficient fiber fermentation, more butyrate available to fuel colon cells, and biological signals consistent with a calmer, more selective immune response. People often experience steadier digestion when butyrate production is adequate, which can translate into less reactivity to routine dietary shifts. There is no universal target—your personal best depends on your overall microbiome, dietary pattern, and life stage.
If Eubacterium rectale is low, that can indicate reduced butyrate capacity, sometimes seen after antibiotics, during prolonged low‑fiber or highly processed eating patterns, or alongside broader dysbiosis. You might also see other signs of imbalance on a comprehensive report, such as lower diversity or higher representation of inflammation‑associated taxa. This is a prompt for exploration rather than a diagnosis. Mechanistically, improving the supply of fermentable substrates can encourage butyrate pathways, and if symptoms persist or systemic markers are abnormal, medical evaluation helps rule out underlying conditions.
Companion Reads for a Eubacterium rectale Result
Big picture, this single‑species readout is most powerful when paired with other data—stool inflammation markers (e.g., calprotectin), overall microbiome diversity, and systemic labs such as HbA1c or hs‑CRP—to align your gut findings with metabolic and inflammatory status. Interpreting trends across time matters more than any one result. If Eubacterium rectale rises in step with more dietary fiber variety and your digestion steadies, that pattern suggests your microbiome is converting inputs into protective outputs.
FAQs
The Eubacterium rectale Test analyzes the genetic material of bacteria, fungi, and other microorganisms in a stool sample to identify species diversity, relative abundance, and inferred functional potential (for example, metabolic pathways and microbial capabilities).
Results describe the composition and balance of the gut microbiome—which species are present and in what amounts and what functions they may perform—but do not directly diagnose disease or prove the presence of a specific illness.
The Eubacterium rectale test is collected with a simple at‑home stool sample kit: you use the small swab or vial provided to take a tiny amount of stool, place it into the supplied container, seal it, and prepare it for return according to the kit instructions.
Maintain cleanliness to avoid contamination (wash hands before and after, use a clean surface), clearly label the sample with the required information (name, date), and follow the kit’s collection, storage, and shipping directions exactly—these steps are essential for accurate sequencing results.
Eubacterium rectale test results can reveal insights about digestion (it’s a common fiber‑fermenting, short‑chain fatty acid–producing species that supports colon health), inflammation (lower or altered levels are often associated with pro‑inflammatory states), nutrient absorption (microbial activity influences availability and synthesis of certain vitamins and minerals), metabolism (associations exist between its abundance and metabolic markers such as weight and glucose regulation), and gut–brain communication (microbial metabolites can affect immune signaling and neural pathways that influence mood and cognition).
These microbiome patterns can correlate with—but do not diagnose—specific health conditions; a single species’ level is one piece of information that must be interpreted alongside your overall microbiome profile, symptoms, medical history, medications, and clinical tests, so discuss results with a healthcare professional for clinical interpretation and next steps.
Next‑generation sequencing (NGS) methods provide high‑resolution microbial data and can sensitively detect and quantify Eubacterium rectale, but the interpretation of Eubacterium rectale test results is probabilistic — results are relative abundance estimates with detection limits, potential strain‑level ambiguity, and dependence on reference databases and bioinformatics pipelines rather than absolute certainties.
Test results represent a snapshot in time and can change with recent diet, stress, sampling technique, bowel transit, or recent antibiotic use; laboratory methods and sample handling also affect reliability, so results are best interpreted alongside clinical context and, if needed, by repeating testing or combining with other clinical information.
Many people test their Eubacterium rectale once per year to establish a baseline, and more frequently—every 3–6 months—when actively changing diet, starting or adjusting probiotics, medications, or other interventions to monitor how the microbiome responds.
Comparing trends over time is more valuable than any single reading: repeated tests reveal direction and consistency of change, help distinguish normal variation from meaningful shifts, and provide better guidance for adjusting interventions.
Yes — microbial populations, including Eubacterium rectale, can shift within days in response to dietary or lifestyle changes; however, while short-term fluctuations happen quickly, more stable abundance patterns and baseline community structure generally emerge over weeks to months.
For meaningful comparisons or retesting, try to keep diet and lifestyle consistent for several weeks before sampling (and avoid recent antibiotics or major dietary shifts); waiting ~4–12 weeks gives the gut microbiota time to stabilize so results are more comparable.
References
- Mukherjee, A., Lordan, C., Ross, R. P., & Cotter, P. D. (2020). Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes, 12(1), 1802866. https://doi.org/10.1080/19490976.2020.1802866
- Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, 277. https://doi.org/10.3389/fimmu.2019.00277
- Paone, P., & Cani, P. D. (2020). Mucus barrier, mucins and gut microbiota: The expected slimy partners? Gut, 69(12), 2232-2243. https://doi.org/10.1136/gutjnl-2020-322260
- Laudadio, I., Fulci, V., Palone, F., Stronati, L., Cucchiara, S., & Carissimi, C. (2018). Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. OMICS, 22(4), 248-254. https://doi.org/10.1089/omi.2018.0013
- Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O'Toole, P. W., Raes, J., Hold, G., Putignani, L., Hvas, C. L., Nieuwdorp, M., Sokol, H., Ianiro, G., & Cammarota, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X






































.avif)
